✦ LIBER ✦

Abatacept for severe anti–tumor necrosis factor α refractory juvenile idiopathic arthritis–related uveitis

✍ Scribed by Francesco Zulian; Marta Balzarin; Fernanda Falcini; Giorgia Martini; Maria Alessio; Rolando Cimaz; Luca Cimino; Maria Elisabetta Zannin

Publisher: Wiley (John Wiley & Sons)
Year: 2010
Tongue: English
Weight: 70 KB
Volume: 62
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.20115

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical outcomes after withdrawal of an

Clinical outcomes after withdrawal of anti–tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: A twelve-year experience

✍ Kevin Baszis; Jane Garbutt; Dana Toib; Jingnan Mao; Allison King; Andrew White; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Efficacy of repeated intravenous infusio

Efficacy of repeated intravenous infusions of an anti–tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study

✍ Valeria Gerloni; Irene Pontikaki; Maurizio Gattinara; Francesca Desiati; Elide L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

A comparison of response criteria to eva

A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti–tumor necrosis factor α agents

✍ A. Lurati; I. Pontikaki; B. Teruzzi; F. Desiati; V. Gerloni; M. Gattinara; R. Ci 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views